Atlas Trials

T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System

Clinical trial NCT02662348 · UNKNOWN

Trial details

NCT number
NCT02662348
Sponsor
Yi Miao
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Esophageal CancerGastric CancerPancreatic CancerLiver CancerGallbladder CancerBowel Cancer
Start date
2016-02-01
Primary completion
2017-11-01
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.